Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumateperone vs Risperidone in First Episode Psychosis
NCT05890768Phase 4Withdrawn
- Sponsor
- The University of New Mexico
- Start
- May 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lumateperone in psychosis, sponsored by The University of New Mexico. Planned start May 2023; status: withdrawn.
02
Drugs
lumateperone
03
Conditions
psychosis
Beyond the preview
Go deeper on NCT05890768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05890768.